Multiple myeloma (MM) is a haematological malignancy characterised by the clonal expansion of monoclonal immunoglobulin-secreting plasma cells in the bone marrow (BM). MM is associated with lytic bone lesions, anaemia, immunodeficiency, and renal impairment. Multiple myeloma accounts for over 10% of all hematologic malignancies and about 1% of all cancers. Multiple myeloma remains mostly incurable despite conventional intensive high dose chemo...
CHF 409.00
